ConductScience.org, home

Paper1161029

N6, O2'-dimethyladenosine a novel methylated ribonucleoside next to the 5' terminal of animal cell and virus mRNAs.

Wei C and 2 others. Nature, 1975. Cited by 210 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. N6, O2'-dimethyladenosine a novel methylated ribonucleoside next to the 5' terminal of animal cell and virus mRNAs. Papers, record 1161029. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1161029

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
N6, O2'-dimethyladenosine a novel methylated ribonucleoside next to the 5' terminal of animal cell and virus mRNAs.
PubMed
Journal
Nature
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
210
iCite
Relative citation ratio, by iCite
2.94
iCite
Revised in PubMed
2026-10-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wei CC
2Gershowitz AA
3Moss BB

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenosineMajor topic
RNA, MessengerMajor topic
RNA, ViralMajor topic
Adenoviridae
HeLa Cells
L Cells
Methylation
Ribonucleosides

Source PubMed

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,168,101The methylated constituents of L cell messenger RNA: evidence for an unusual cluster at the 5' terminus.Cell1975https://conductscience.org/library/papers/1168101PubMed
2163,011A blocked structure at the 5' terminus of mRNA from cytoplasmic polyhedrosis virus.Nature1975https://conductscience.org/library/papers/163011PubMed
31,057,180Methylated, blocked 5 termini in HeLa cell mRNA.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1057180PubMed
4165,901Methylated and blocked 5' termini in vesicular stomatitis virus in vivo mRNAs.Cell1975https://conductscience.org/library/papers/165901PubMed
5164,018Methylated nucleotides block 5'-terminus of vaccinia virus messenger RNA.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/164018PubMed
6165,487Methylation-dependent translation of viral messenger RNAs in vitro.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/165487PubMed
7164,293Methylated nucleotides block 5' terminus of HeLa cell messenger RNA.Cell1975https://conductscience.org/library/papers/164293PubMed
81,054,511Reovirus messenger RNA contains a methylated, blocked 5'-terminal structure: m-7G(5')ppp(5')G-MpCp-.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1054511PubMed
9165,189Nucleotide sequence of U-2 ribonucleic acid. The sequence of the 5'-terminal oligonucleotide.J Biol Chem1975https://conductscience.org/library/papers/165189PubMed
10165,900The 5' terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus.Cell1975https://conductscience.org/library/papers/165900PubMed
111,128,665Modified nucleosides and bizarre 5'-termini in mouse myeloma mRNA.Nature1975https://conductscience.org/library/papers/1128665PubMed
121,058,472Modification of the 5'-terminus of mRNA by soluble guanylyl and methyl transferases from vaccinia virus.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1058472PubMed

Cited by144

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 210 citations.

PMIDTitleJournalYearIn PapersSource
42,754,163RNA Demethylase FTO Uses Conserved Aromatic Residues to Recognize the mRNA 5' Cap and Promote Efficient m6Am Demethylation.J Biol Chem2026https://conductscience.org/library/papers/42754163PubMed
42,613,369Blocking the m6Am methyltransferase PCIF1 in macrophages attenuates colitis progression by preventing neuronal damage.Cell Mol Immunol2026https://conductscience.org/library/papers/42613369PubMed
42,509,238Blocking the m6Am methyltransferase PCIF1 releases STAT1-mediated Th1 immunity to potentiate cancer immunotherapy.Nat Commun2026https://conductscience.org/library/papers/42509238PubMed
42,245,481FTO in cardiovascular diseases: mechanisms, context dependence, and translational opportunities.Front Cell Dev Biol2026https://conductscience.org/library/papers/42245481PubMed
42,239,405FTO separation-of-function mutations alter m6A versus m6Am demethylation selectivity on RNA.bioRxiv2026https://conductscience.org/library/papers/42239405PubMed
41,940,144Detection technologies for RNA modifications and their applications in plants.aBIOTECH2026https://conductscience.org/library/papers/41940144PubMed
41,824,765Programmable RNA N6,2´-O-Dimethyladenosine Editing.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41824765PubMed
41,677,666PCIF1 Attenuates Type I Interferon Induction by Inhibiting IRF3 Activation in a Methyltransferase-Independent Manner.Cells2026https://conductscience.org/library/papers/41677666PubMed
41,665,006The dynamic landscape and conserved regulation of the m6Am and m6A methylomes during the human and mouse oocyte-to-embryo transition.Nucleic Acids Res2026https://conductscience.org/library/papers/41665006PubMed
41,619,255The 5' Cap Epitranscriptome and Beyond: Natural and Engineered 5' Cap Modifications for Optimizing mRNA Therapeutics and Functional Studies.ChemMedChem2026https://conductscience.org/library/papers/41619255PubMed
41,446,042RNA modifications in health and disease: from mechanistic insights to therapeutic applications.Precis Clin Med2025https://conductscience.org/library/papers/41446042PubMed
41,195,338Epitranscriptomic signatures in blood: emerging biomarkers for diagnosis of diabetes and its complications.Front Cell Dev Biol2025https://conductscience.org/library/papers/41195338PubMed
41,163,078Hypoxia-mediated regulation of mRNA metabolism: from transcription to stability.Cell Commun Signal2025https://conductscience.org/library/papers/41163078PubMed
40,874,592Evidence human FTO catalyses hydroxylation of N6-methyladenosine without direct formation of a demethylated product contrasting with ALKBH5/2/3 and bacterial AlkB.Nucleic Acids Res2025https://conductscience.org/library/papers/40874592PubMed
40,823,695The functional and therapeutic potential of epitranscriptomics in breast cancer.Epigenomics2025https://conductscience.org/library/papers/40823695PubMed
40,764,612SERBP1-PCIF1 complex-controlled m6Am modification in glutamatergic neurons of the primary somatosensory cortex is required for neuropathic pain in mice.Nat Commun2025https://conductscience.org/library/papers/40764612PubMed
40,573,386The Role of Chemical Modifications in the Genome of Negative-Sense RNA Viruses on the Innate Immune Response.Viruses2025https://conductscience.org/library/papers/40573386PubMed
40,488,318Chemically modified non-coding RNAs in cancer.Expert Rev Mol Med2025https://conductscience.org/library/papers/40488318PubMed
40,437,520RNA multi-omics in single cells reveal rhythmical RNA reshaping during human and mouse oocyte maturation.BMC Biol2025https://conductscience.org/library/papers/40437520PubMed
40,351,534RNA modifications and their role in gene expression.Front Mol Biosci2025https://conductscience.org/library/papers/40351534PubMed

See all 144 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1161029

GET https://conductscience.org/api/papers/v1/1161029/cited_by?page=2